Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity

Blood

Volumn 100, Issue 4, 2002, Pages 1502-1504

  Schmitz, Marc ^a   Zhao, Senming ^a   Schäkel, Knut ^a   Bornhäuser, Martin ^a   Ockert, Detlef ^a   Rieber, Ernst Peter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; FC RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M DC8; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037103303     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.4.1502.h81602001502_1502_1504     Document Type: Article

References (22)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Dendritic cells and the control of immunity
3. Immunobiology of dendritic cells
4. Dendritic cells in cancer immunotherapy
5. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells
6. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
7. 2+-dependent mechanism
8. A novel dendritic cell population in human blood: One-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes
9. Signal transduction during natural killer cell activation: Inside the mind of a killer
10. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells
11. Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties
12. T-cell section report
13. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
14. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER
15. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor: Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays
16. Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications
17. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells
18. Effect of recombinant interferon-gamma (IFN-gamma) on the mechanism of human macrophage IgG FcRI mediated cytotoxicity: rIFN-gamma decreases inhibition of cytophilic human IgG and changes the cytolytic mechanism
19. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes
20. Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during antitumour antibody-dependent cell-mediated cytotoxicity
21. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway
22. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas